Secret Session Funds Tiny Medical Book Ideas
Published Date: 3/17/2025
Notice
Summary
The National Library of Medicine is holding a closed virtual meeting on April 17, 2025, to review special grant applications related to small business research. This meeting is private to protect secret ideas and personal info, so only committee members will join. If you’re involved in these grants, this is when decisions get made—no public access or money changes announced yet.
Analyzed Economic Effects
2 provisions identified: 1 benefits, 1 costs, 0 mixed.
SBIR/STTR Applications Kept Confidential
If you applied for an SBIR or STTR grant, your application will be reviewed at a closed meeting on April 17, 2025 from 10:30 a.m. to 3:00 p.m. The meeting is closed to protect confidential trade secrets, patentable materials, commercial property, and personal information about people associated with the applications.
Meeting Closed — No Public Access
The National Library of Medicine will hold a virtual, closed meeting on April 17, 2025 to review and evaluate SBIR and STTR grant applications, and the meeting will not be open to the public. Only committee members will attend, and there will be no public access at the meeting to observe deliberations or receive announcements of funding decisions there.
Personalized for You
How does this regulation affect your finances?
Personalize government policy and PRIA will tell you what this federal register document means for your household, plus every other regulation we track. PRIA reads each provision against your financial profile to show you exactly what matters to your wallet.
Key Dates
Department and Agencies
Related Federal Register Documents
2026-17438, Center For Scientific Review; Notice of Closed Meetings
The NIH's Center for Scientific Review is holding several closed virtual meetings in late September 2026 to review and evaluate grant applications. These meetings protect private info and trade secrets, affecting researchers applying for funding. No direct money changes are announced, but these reviews decide who gets research grants.
2026-16683, Proposed Collection; 60-Day Comment Request; Data Use Certification for the NIH National Institute on Drug Abuse Data Share Site
The purpose of this notice is to inform the public of the information collection requirement for the NIDA Data Share, the data use terms and conditions, and to request a progress report statement at the time of renewal. In compliance with the requirement of the Paperwork Reduction Act of 1995 to provide opportunity for public comment on proposed data collection projects, the National Institute on Drug Abuse (NIDA) will publish periodic summaries of proposed projects to be submitted to the Office of Management and Budget (OMB) for review and approval.
2026-16544, Government-Owned Inventions; Availability for Licensing
The inventions listed below are owned by an agency of the U.S. Government and are available for licensing to achieve expeditious commercialization of results of federally-funded research for the benefit of the public health.
2026-16440, NIH Owned Invention Available for License: Soluble Tissue Factor, a Novel Target, and Antibodies, for Diagnosis, Prevention and Treatment of Thrombosis and Related Conditions
Scientists at the National Cancer Institute (NCI) have discovered a novel therapeutic, diagnostic and prognostic target for thrombosis: Soluble Tissue Factor (sTF). NCI has generated first-in- class antibodies and platform selectively neutralizing pathological coagulation while preserving normal hemostasis. This platform technology can be used to prevent, diagnose and treat pathological thrombosis caused by a variety of clinical conditions-including cancer, sepsis, infectious diseases (e.g., COVID), autoimmune disorders, trauma, heart conditions and inflammatory conditions. It offers a much more sensitive and specific test of thrombosis than the current D-dimer test. It may be applicable to any clinical condition which induces necroptosis, pyroptosis and NETtosis, such as cancer, neurodegenerative disease, ischemia-reperfusion and acute injuries, traumatic injuries, bacterial and viral infections, cardiovascular conditions, and atherosclerosis, inflammatory, autoimmune conditions, and others.
2026-16071, Proposed Collection; 60-Day Comment Request: The Impact of Clinical Research Training and Medical Education at the Clinical Center on Physician Careers in Academia and Clinical Research (Clinical Center)
In compliance with the requirement of the Paperwork Reduction Act of 1995, for opportunity for public comment on proposed data collection projects, the Clinical Center, the National Institutes of Health (NIH) will publish periodic summaries of proposed projects to be submitted to the Office of Management and Budget (OMB) for review and approval.
2026-15565, Proposed Collection; 60-Day Comment Request, Data Use Certification for the NIH Brain Development Cohorts (NBDC) Data Hub, (National Institute on Drug Abuse)
In compliance with the requirement of the Paperwork Reduction Act of 1995 to provide opportunity for public comment on proposed data collection projects, the National Institute on Drug Abuse (NIDA) will publish periodic summaries of proposed projects to be submitted to the Office of Management and Budget (OMB) for review and approval. The purpose of this revision is to update instructions for the Research Data Use Statement and the Progress Report, and to add new instructions for attesting to National Institute of Standards & Technology (NIST) security compliance, and for a Project Close-out at the time of project completion. Burden levels remain unchanged.
Previous / Next Documents
Previous: 2025-04294, Environmental Management Site-Specific Advisory Board Chairs
The Environmental Management Site-Specific Advisory Board (EM SSAB) is holding a virtual meeting open to the public. This notice lets everyone know when and how to join, keeping the process transparent and easy to follow. If you care about cleaning up the environment, this is your chance to get involved—no cost to attend!
Next: 2025-04297, Intent To Request Extension From OMB of One Current Public Collection of Information: TSA Customer Comment Card
TSA wants to keep using its Customer Comment Card so travelers can share feedback, ask for help, or report security issues at checkpoints. This extension means TSA can keep improving your airport experience without charging you extra or causing delays. If you’ve got thoughts about TSA’s service, now’s your chance to speak up before the extension is approved!